Susan Schneider

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 859 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +4

Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results

Peter K. Kaiser, David M. Brown, Kang Zhang et al. · American Journal of Ophthalmology · 2007 · 363 citations

Ocular Disease, Ophthalmology, Age-related Diseases +6

Population-Based Incidence of Uveal Melanoma in Various Races and Ethnic Groups

Dan‐Ning Hu, Guo‐Pei Yu, Steven A. McCormick et al. · American Journal of Ophthalmology · 2005 · 237 citations

Ethnicity, Uveal Melanoma, Ophthalmology +9

Visualizing vitreous using Kenalog suspension

Scott Burk, Andrea P. Da Mata, Michael E. Snyder et al. · Journal of Cataract & Refractive Surgery · 2003 · 143 citations

Real-time Visualization, Vitreous Body, Ophthalmology +10